Related references
Note: Only part of the references are listed.Sweetening the Pot: Adding Glycosylation to the Biomarker Discovery Equation
Penelope M. Drake et al.
CLINICAL CHEMISTRY (2010)
Proposal for a standard system for drawing structural diagrams of N- and O-linked carbohydrates and related compounds
David J. Harvey et al.
PROTEOMICS (2009)
HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software
Louise Royle et al.
ANALYTICAL BIOCHEMISTRY (2008)
Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles
Zuzana Kyselova et al.
CLINICAL CHEMISTRY (2008)
Glycosylation changes on serum glycoproteins in ovarian cancer may contribute to disease pathogenesis
Radka Saldova et al.
DISEASE MARKERS (2008)
A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression
Umi M. Abd Hamid et al.
GLYCOBIOLOGY (2008)
Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation
James N. Arnold et al.
PROTEOMICS (2008)
Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG
Radka Saldova et al.
GLYCOBIOLOGY (2007)
A serum glycomics approach to breast cancer biomarkers
Crystal Kirmiz et al.
MOLECULAR & CELLULAR PROTEOMICS (2007)
Serum tumor markers in breast cancer: Are they of clinical value?
MJ Duffy
CLINICAL CHEMISTRY (2006)
Clinical utility of cytokeratins as tumor markers
V Barak et al.
CLINICAL BIOCHEMISTRY (2004)
The discovery, biology, and drug development of sialyl Lea and sialyl Lex
JL Magnani
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2004)
Share Paper
